Serdexmethylphenidate and Dexmethylphenidate Uses, Dosage, Side Effects and Interactions
Azstarys
Azstarys was the first serdexmethylphenidate and dexmethylphenidate product the FDA approved, in May 2021. No generic is listed as capsules.
Serdexmethylphenidate and dexmethylphenidate is a CNS stimulant combination used to treat Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older.
Quick links
Ask Anything About Serdexmethylphenidate and DexmethylphenidateType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Serdexmethylphenidate and Dexmethylphenidate in Short
- Drug class Central Nervous System Stimulant How the FDA classifies it
What it treatsAzstarys is approved to treat Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older, including children, adolescents, and adults. It is a central nervous system (CNS) stimulant that helps manage the inattention, hyperactivity, and impulsivity associated with ADHD.
- How you get it Prescription only Controlled substance, Schedule II
- Comes asCapsule (by mouth)Available strengths (serdexmethylphenidate/dexmethylphenidate)
- 26.1 mg/5.2 mg
- 39.2 mg/7.8 mg
- 52.3 mg/10.4 mg
- The FDA’s strongest warningBoxed warning The FDA’s most serious alert. Read what it says
- Supplements and herbs91 interact 10 major, 67 moderate and 14 minor
- What pharmacies pay
- Azstarys (brand)$14.39 to $14.41 a capsule
- Generic launchDecember 2037 Our estimate for the first generic of Azstarys
The Pharmacist’s Take
Azstarys is a long-acting stimulant for ADHD in people 6 and older, from the methylphenidate family that is a usual first choice, pairing quick-acting dexmethylphenidate with serdexmethylphenidate, a prodrug the body slowly turns into the same active drug, to raise dopamine and norepinephrine activity through the day; on the market since about 2021, it is not yet available as a generic. Most people tolerate it about as well as other methylphenidate medicines, mainly noticing a smaller appetite and trouble sleeping. Its boxed warning covers abuse, misuse and addiction, so take it exactly as prescribed, keep it locked up and never share it.
Key Takeaways From the HelloPharmacist Team
- Take it once in the morning; if swallowing is hard, open the capsule onto applesauce or into water and finish within 10 minutes.
- Expect a dose review after the first week, when it may be raised or lowered depending on how it works and feels.
- Expect blood pressure and heart rate checks at follow-up visits, plus regular height and weight checks for children taking it.
- Get emergency care right away for chest pain, shortness of breath or fainting, and call the prescriber about hallucinations or extreme mood changes.
FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Serdexmethylphenidate and Dexmethylphenidate.
Azstarys has a high potential for abuse, misuse, and addiction. Like other CNS stimulants, it can be misused — especially if taken at higher doses or by methods other than swallowing (such as snorting or injecting). This misuse can lead to overdose and death. Anyone taking Azstarys should be assessed for their risk of abuse before starting treatment, and monitored throughout. Keep it stored safely, preferably locked up, never share it with anyone else, and dispose of any unused medication properly. Signs of misuse include taking more than prescribed, using it to get high, or craving the drug.
Patient Information Guide for Serdexmethylphenidate and Dexmethylphenidate
What It’s Used For
Serdexmethylphenidate and dexmethylphenidate is a CNS stimulant combination approved for the following use:
- Azstarys (oral capsule) is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older, including children, adolescents, and adults.
- Azstarys is not recommended for children under 6, as this age group experiences greater drug exposure and a higher rate of adverse reactions, such as weight loss, compared to older patients at the same dose.
How It Works
Serdexmethylphenidate is a prodrug — an inactive form that the body converts into the active medicine, dexmethylphenidate, primarily in the lower gastrointestinal tract. Dexmethylphenidate is a CNS stimulant that blocks the reuptake (reabsorption) of two brain chemicals, norepinephrine and dopamine, and also promotes their release. This raises the levels of both chemicals in the synaptic space between nerve cells. Exactly how this translates to ADHD symptom improvement is not fully understood.
Drug Class
Drug Class
- Central Nervous System Stimulant from dexmethylphenidate
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Serdexmethylphenidate and Dexmethylphenidate has two active ingredients, so each class says which one it comes from.
Drug Class
Established Pharmacologic Class (EPC)- Central Nervous System Stimulant from dexmethylphenidate
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)None listed for Serdexmethylphenidate and Dexmethylphenidate in the FDA’s index.
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)- Central Nervous System Stimulation from dexmethylphenidate
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)None listed for Serdexmethylphenidate and Dexmethylphenidate in the FDA’s index.
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Centrally acting sympathomimetics
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Azstarys is taken orally once every morning, with or without food. Eating does slow the time it takes to reach peak levels in the blood, but does not meaningfully change the overall amount absorbed.
The capsule can be swallowed whole or opened and mixed into water or applesauce — any mixture must be consumed immediately (within 10 minutes) and cannot be stored.
- Azstarys is always dosed once daily in the morning.
- It is not interchangeable milligram-for-milligram with other methylphenidate products — always follow your prescriber's specific dose instructions.
- If symptoms worsen or side effects are bothersome, talk to your prescriber before making any changes.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
ADHD (attention deficit hyperactivity disorder)
Adults and teens 13 to 17 years old · Starting dose Starting dose 39.2 mg serdexmethylphenidate/7.8 mg dexmethylphenidate once daily in the morning
Good to know
Administer with or without food
Adults and teens 13 to 17 years old · After one week Usual dose 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate once daily Highest dose 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate once daily
- Increase to 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate once daily after one week, depending on response and tolerability
Children 6 to 12 years old · Starting dose Starting dose 39.2 mg serdexmethylphenidate/7.8 mg dexmethylphenidate once daily in the morning
Good to know
Administer with or without food
Children 6 to 12 years old · After one week Highest dose 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate once daily
- May be increased to 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate per day, or decreased to 26.1 mg serdexmethylphenidate/5.2 mg dexmethylphenidate per day, after one week, depending on response and tolerability
Side Effects
The most commonly reported side effects with methylphenidate products include:
Common side effects
- Decreased appetite
- Trouble sleeping (insomnia)
- Nausea or vomiting
- Stomach pain or upset stomach
- Weight loss
- Irritability or mood swings
- Increased heart rate or blood pressure
- Dizziness
- Anxiety or irritability
When to get medical help
- Chest pain, shortness of breath, or fainting — seek emergency care right away
- Signs of psychosis or mania: hallucinations, delusions, or extreme mood changes — call your doctor
- Painful or prolonged erections (priapism) — seek immediate medical attention
- Numbness, coldness, or color changes in fingers or toes (signs of Raynaud's phenomenon) — tell your doctor
- Children not growing or gaining weight as expected — discuss with your doctor
- Signs of abuse or addiction — talk to your prescriber
- Eye pain or vision changes — contact your doctor promptly
- New or worsening tics, or worsening Tourette's syndrome — tell your doctor
More serious reactions — including chest pain, hallucinations, signs of psychosis or mania, painful erections, or severe allergic reactions — require prompt medical attention. In children, slowed growth in height and weight has been observed with long-term use and should be monitored by the prescriber.
Warnings and Precautions
- Abuse, misuse, and addiction: Azstarys is a federally controlled stimulant with a high potential for abuse. Misuse — especially snorting or injecting — can cause overdose and death. Store it securely, never share it, and dispose of leftovers properly.
- Heart risks: Sudden death has been reported in people with pre-existing structural heart problems taking CNS stimulants. Azstarys should not be used in patients with serious heart disease. It also raises blood pressure and heart rate, so regular monitoring is needed for everyone.
- Psychiatric effects: Azstarys can trigger or worsen psychosis, hallucinations, or mania — even in people with no prior psychiatric history. Patients with bipolar disorder or a family history of mental illness should be carefully screened before starting.
- Growth suppression in children: Long-term use has been linked to lower-than-expected gains in height and weight in pediatric patients. Height and weight should be tracked regularly, and treatment may need to be paused if growth is significantly affected.
- Priapism: Prolonged, painful erections have been reported in both adults and children on methylphenidate. Seek immediate medical help if this occurs.
- Peripheral vasculopathy (poor circulation): Raynaud's phenomenon — numbness, color changes, or ulcers in the fingers or toes — has been reported. Report any such changes to your doctor.
- Eye pressure: Azstarys has been linked to increased intraocular pressure and angle-closure glaucoma. Patients with glaucoma or significant farsightedness should be evaluated by an eye doctor.
- Tics and Tourette's syndrome: Azstarys can trigger or worsen motor or verbal tics. Patients should be evaluated before starting treatment and monitored throughout.
Interactions
Azstarys can interact with several medications — always tell your prescriber and pharmacist everything you take:
- MAOIs (e.g., phenelzine, selegiline, tranylcypromine): Combining with Azstarys can trigger a hypertensive crisis — a sudden, dangerous spike in blood pressure that can be fatal. Azstarys must never be taken with an MAOI, or within 14 days of stopping one.
- Blood pressure medications (antihypertensives): Azstarys can blunt the effectiveness of these drugs. Blood pressure should be monitored more closely, and the antihypertensive dose may need adjustment.
- Halogenated anesthetics (used during surgery): This combination can cause sudden, dangerous increases in blood pressure and heart rate. Azstarys should be avoided on the day of any surgical procedure requiring anesthesia.
- Risperidone: When used together with methylphenidate, dosage changes in either drug may increase the risk of extrapyramidal symptoms (EPS) — movement-related side effects like stiffness, tremors, or restlessness.
Interactions Listed in the FDA-Approved Label
From the Serdexmethylphenidate and Dexmethylphenidate prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Monoamine oxidase inhibitors (MAOIs)What happensConcomitant use with CNS stimulants, including AZSTARYS, can cause hypertensive crisis, with potential outcomes including death, stroke, myocardial infarction, aortic dissection, ophthalmological complications, eclampsia, pulmonary edema, and renal failure.What to doDo not administer AZSTARYS concomitantly with MAOIs or within 14 days after discontinuing MAOI treatment.
-
Antihypertensive drugsWhat happensAZSTARYS may decrease the effectiveness of drugs used to treat hypertension.What to doMonitor blood pressure and adjust the dosage of the antihypertensive drug, as needed.
-
Halogenated anestheticsWhat happensConcomitant use may increase the risk of sudden blood pressure and heart rate increase during surgery.What to doAvoid use of AZSTARYS in patients being treated with anesthetics on the day of surgery.
-
What happensCombined use with methylphenidate when there is a change, increase or decrease, in dosage of either or both medications may increase the risk of extrapyramidal symptoms (EPS).What to doMonitor for signs of EPS.
Read the label’s full interactions text
7 DRUG INTERACTIONS Antihypertensive Drugs: Monitor blood pressure. Adjust dosage of antihypertensive drug as needed. 7.1 Clinically Important Interactions with AZSTARYS Table 1 presents clinically important drug interactions with AZSTARYS. Table 1: Clinically Important Drug Interactions with AZSTARYS Monoamine Oxidase Inhibitors (MAOIs) Clinical Impact Concomitant use of MAOIs and CNS stimulants, including AZSTARYS, can cause hypertensive crisis. Potential outcomes include death, stroke, myocardial infarction, aortic dissection, ophthalmological complications, eclampsia, pulmonary edema, and renal failure. Intervention Do not administer AZSTARYS concomitantly with MAOIs or within 14 days after discontinuing MAOI treatment Antihypertensive Drugs Clinical Impact AZSTARYS may decrease the effectiveness of drugs used to treat hypertension. Intervention Monitor blood pressure and adjust the dosage of the antihypertensive drug, as needed. Halogenated Anesthetics Clinical Impact Concomitant use of halogenated anesthetics and AZSTARYS may increase the risk of sudden blood pressure and heart rate increase during surgery. Intervention Avoid use of AZSTARYS in patients being treated with anesthetics on the day of surgery. Risperidone Clinical Impact Combined use of methylphenidate with risperidone when there is a change, whether an increase or decrease, in dosage of either or both medications, may increase the risk of extrapyramidal symptoms (EPS). Intervention Monitor for signs of EPS.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not take Azstarys if you are allergic to serdexmethylphenidate, methylphenidate, or any ingredient in the capsule.
- Do not take Azstarys if you are currently taking an MAOI or have taken one within the past 14 days.
- Tell your doctor if you have any heart problem, including structural abnormalities, arrhythmias, coronary artery disease, or cardiomyopathy — Azstarys may not be appropriate.
- Tell your doctor if you have a personal or family history of bipolar disorder, depression, psychosis, or suicidal thoughts.
- Tell your doctor if you or a family member has a history of motor or verbal tics or Tourette's syndrome.
- Tell your doctor if you have glaucoma or elevated eye pressure — Azstarys requires extra caution and monitoring in these patients.
- Pregnancy: There are no well-controlled studies of Azstarys in pregnant women. CNS stimulants may reduce blood flow to the placenta. Discuss the risks and benefits with your doctor; a National Pregnancy Registry is available at 1-866-961-2388.
- Breastfeeding: Dexmethylphenidate may pass into breast milk. Monitor breastfed infants for agitation, poor appetite, or slow weight gain, and discuss with your doctor whether to continue.
- Children under 6: Azstarys is not approved or recommended for this age group.
- Discuss your personal risk of substance misuse or addiction with your prescriber before starting Azstarys.
Overdose
Taking too much Azstarys can cause serious, life-threatening effects including rapid or irregular heartbeat, very high or low blood pressure, agitation, confusion, hallucinations, seizures, dangerously high body temperature, and in severe cases, coma or death. If you suspect an overdose, call the Poison Help line at 1-800-222-1222 or go to an emergency room immediately — and tell providers all medications taken, since multiple drug ingestion is possible.
Half-Life and How Your Body Processes It
Serdexmethylphenidate is absorbed from the gut and converted to dexmethylphenidate mainly in the lower gastrointestinal tract, with the active drug reaching peak blood levels in about 2 hours under fasted conditions — slightly longer (4 to 4.5 hours) when taken with food. The prodrug itself has very low direct oral bioavailability (less than 3%), ensuring most activity comes from dexmethylphenidate. Dexmethylphenidate has a half-life of about 11.7 hours, meaning it takes roughly that long for the body to clear half of it, and steady-state levels are reached after about three days of once-daily dosing. The drug is primarily broken down (metabolized) into an inactive compound called ritalinic acid and excreted mostly through the urine.
Storage
Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). Protect from moisture. Dispense in tight container (USP).
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Supplements and Herbs That Interact With Serdexmethylphenidate and Dexmethylphenidate
From the licensed clinical database we use, rolled up per supplement, most serious first.91 supplements and herbal products have documented interactions with Serdexmethylphenidate and Dexmethylphenidate in the licensed clinical database we use.
Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.
- 10Major
- 67Moderate
- 14Minor
- ACTIVATED CHARCOALMajor
- AMERICAN HELLEBOREMajor
- ARSENICMajor
- CESIUMMajor
- EPHEDRAMajor
- GRAPEFRUITMajor
- LITHIUMMajor
- PEYOTEMajor
Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Serdexmethylphenidate and Dexmethylphenidate: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Serdexmethylphenidate and Dexmethylphenidate — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly does Azstarys do, and why was I prescribed it?
Can I open the capsule if I (or my child) have trouble swallowing it?
What side effects should I watch out for vs. what's okay to just ride out?
Is this medication addictive? I'm worried about taking a controlled substance.
Are there medications or supplements I need to avoid while taking Azstarys?
Is it safe to take Azstarys during pregnancy or while breastfeeding?
Is serdexmethylphenidate and dexmethylphenidate available over the counter?
Is serdexmethylphenidate and dexmethylphenidate a controlled substance?
When was serdexmethylphenidate and dexmethylphenidate first available?
What is the brand name of serdexmethylphenidate and dexmethylphenidate?
What is the generic name of Azstarys?
What drug class is serdexmethylphenidate and dexmethylphenidate?
What strengths does serdexmethylphenidate and dexmethylphenidate come in?
How much does serdexmethylphenidate and dexmethylphenidate cost?
Where can I read the serdexmethylphenidate and dexmethylphenidate prescribing information (package insert)?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Serdexmethylphenidate and Dexmethylphenidate
Skip the scrolling. Ask in your own words and get an answer from Serdexmethylphenidate and Dexmethylphenidate’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Serdexmethylphenidate and Dexmethylphenidate’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Serdexmethylphenidate and Dexmethylphenidate on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Serdexmethylphenidate and Dexmethylphenidate Forms and Strengths (How It Comes)
Serdexmethylphenidate and Dexmethylphenidate comes in 1 dose form, the capsule. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Serdexmethylphenidate and Dexmethylphenidate inactive ingredients by manufacturer.
Capsule
How this form is used
- Azstarys capsules are indicated for the treatment of ADHD in patients 6 years of age and older
- Azstarys is not recommended for children under 6 years of age due to higher drug exposure and increased side effects in this age group
- Azstarys capsules are taken once daily in the morning, with or without food
- Azstarys capsules may be swallowed whole, or opened and the full contents sprinkled into 50 mL of water or over 2 tablespoons of applesauce — consume the mixture immediately or within 10 minutes; do not store it
- Azstarys should not be substituted for other methylphenidate products on a milligram-per-milligram basis, as it has a different pharmacokinetic profile
- If switching from another methylphenidate product to Azstarys, stop the previous medication and re-titrate using the Azstarys dosing schedule as directed by your prescriber
Serdexmethylphenidate and Dexmethylphenidate on the U.S. Market: Products, Makers and Brands
How Serdexmethylphenidate and Dexmethylphenidate appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
1 company lists 3 Serdexmethylphenidate and Dexmethylphenidate product records with the FDA, mostly as capsule; the earliest marketing or approval year on record is 2021. The one brand name in the directory today is Azstarys; the rest are generics.
How Widely Serdexmethylphenidate and Dexmethylphenidate Is Used (Medicaid Data)
How many Serdexmethylphenidate and Dexmethylphenidate prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Serdexmethylphenidate and Dexmethylphenidate prescribed? Of the 1,682 medications we measure, Serdexmethylphenidate and Dexmethylphenidate ranks #422 by Medicaid prescriptions — more than 75% of them.
Utilization by Serdexmethylphenidate and Dexmethylphenidate product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
dexmethylphenidate 7.8 MG / serdexmethylphenidate 39.2 MG Oral Capsule Most dispensed
1 of 1 listed NDCs had Medicaid claims. RxNorm 2562191
dexmethylphenidate 10.4 MG / serdexmethylphenidate 52.3 MG Oral Capsule
1 of 1 listed NDCs had Medicaid claims. RxNorm 2562194
dexmethylphenidate 5.2 MG / serdexmethylphenidate 26.1 MG Oral Capsule
1 of 1 listed NDCs had Medicaid claims. RxNorm 2562187
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 3 of the 3 listed Serdexmethylphenidate and Dexmethylphenidate NDCs had Medicaid claims.
Compare Serdexmethylphenidate and Dexmethylphenidate Products
A representative set of FDA-listed product records for Serdexmethylphenidate and Dexmethylphenidate — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| SERDEXMETHYLPHENIDATE CHLORIDE 26.1 mg/1; DEXMETHYLPHENIDATE HYDROCHLORIDE 5.2 mg | Oral | Commave Sub, LLC | NDA | View NDC → |
| SERDEXMETHYLPHENIDATE CHLORIDE 39.2 mg/1; DEXMETHYLPHENIDATE HYDROCHLORIDE 7.8 mg | Oral | Commave Sub, LLC | NDA | View NDC → |
| SERDEXMETHYLPHENIDATE CHLORIDE 52.3 mg/1; DEXMETHYLPHENIDATE HYDROCHLORIDE 10.4 mg | Oral | Commave Sub, LLC | NDA | View NDC → |
Showing 3 of 3 products — FDA National Drug Code Directory. See every product, package size and price: browse all 3 Serdexmethylphenidate and Dexmethylphenidate NDCs →
Serdexmethylphenidate and Dexmethylphenidate Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Serdexmethylphenidate and Dexmethylphenidate — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Serdexmethylphenidate and Dexmethylphenidate in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Serdexmethylphenidate and Dexmethylphenidate FDA Approval History
How Serdexmethylphenidate and Dexmethylphenidate went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Serdexmethylphenidate and Dexmethylphenidate Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Serdexmethylphenidate and Dexmethylphenidate recalls since July 2021.
✅No Serdexmethylphenidate and Dexmethylphenidate recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Serdexmethylphenidate and Dexmethylphenidate in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one exact combination of ingredients (MIN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. A different combination is a different concept with its own page.
- Dose forms
- 1
- Strengths
- 3
- Forms in current FDA listings
- 1 of 1
RxCUI 2562192 -
Dose form (SCDF) Oral CapsuleIn current FDA listings
RxCUI 2562189Its 3 strengths (SCD)-
dexmethylphenidate 5.2 mg / serdexmethylphenidate 26.1 mg
RxCUI 2562187 -
dexmethylphenidate 7.8 mg / serdexmethylphenidate 39.2 mg
RxCUI 2562191 -
dexmethylphenidate 10.4 mg / serdexmethylphenidate 52.3 mg
RxCUI 2562194
-
dexmethylphenidate 5.2 mg / serdexmethylphenidate 26.1 mg
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Serdexmethylphenidate and Dexmethylphenidate Supply and Shortage Status
Whether Serdexmethylphenidate and Dexmethylphenidate is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Serdexmethylphenidate and Dexmethylphenidate Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Serdexmethylphenidate and Dexmethylphenidate: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a strength to see how its price has changed since Nov 2023.
For brand-name Azstarys, the SERDEXMETHYLPHENIDATE CHLORIDE 26.1 mg/1; DEXMETHYLPHENIDATE HYDROCHLORIDE 5.2 mg capsule, pharmacies paid an average of $14.39 per capsule as of Nov 18, 2026, up 3.7% from $13.88 a year earlier.
- What pharmacies pay now
- $14.39
- per capsule, as of Nov 18, 2026
- Last 4 weeks
- No change
- from $14.40 on Oct 21, 2026
- Last 12 months
- Up 3.7%
- from $13.88 on Nov 19, 2025
- Lowest and highest since Nov 2023
- $12.82 to $14.44
- per capsule
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $14.39 |
| Oct 2026 | $14.40 |
| Sep 2026 | $14.40 |
| Aug 2026 | $14.40 |
| Jul 2026 | $14.41 |
| Jun 2026 | $14.41 |
| May 2026 | $14.40 |
| Apr 2026 | $14.44 |
| Mar 2026 | $14.44 |
| Feb 2026 | $14.44 |
| Jan 2026 | $14.44 |
| Dec 2025 | $14.44 |
| Nov 2025 | $13.88 |
| Oct 2025 | $13.88 |
| Sep 2025 | $13.91 |
| Aug 2025 | $13.91 |
| Jul 2025 | $13.91 |
| Jun 2025 | $13.90 |
| May 2025 | $13.91 |
| Apr 2025 | $13.92 |
| Mar 2025 | $13.92 |
| Feb 2025 | $13.92 |
| Jan 2025 | $13.92 |
| Dec 2024 | $13.39 |
| Nov 2024 | $13.38 |
| Oct 2024 | $13.39 |
| Sep 2024 | $13.39 |
| Aug 2024 | $13.40 |
| Jul 2024 | $13.40 |
| Jun 2024 | $13.39 |
| May 2024 | $13.40 |
| Apr 2024 | $13.33 |
| Mar 2024 | $13.33 |
| Feb 2024 | $13.33 |
| Jan 2024 | $13.33 |
| Dec 2023 | $12.82 |
| Nov 2023 | $12.82 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Capsule · Oral | SERDEXMETHYLPHENIDATE CHLORIDE 26.1 mg/1; DEXMETHYLPHENIDATE HYDROCHLORIDE 5.2 mg | Azstarys (brand) | $14.39 per capsule | NDC details & price history |
| Capsule · Oral | SERDEXMETHYLPHENIDATE CHLORIDE 39.2 mg/1; DEXMETHYLPHENIDATE HYDROCHLORIDE 7.8 mg | Azstarys (brand) | $14.41 per capsule | NDC details & price history |
| Capsule · Oral | SERDEXMETHYLPHENIDATE CHLORIDE 52.3 mg/1; DEXMETHYLPHENIDATE HYDROCHLORIDE 10.4 mg | Azstarys (brand) | $14.41 per capsule | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Serdexmethylphenidate and Dexmethylphenidate Brand Names
Serdexmethylphenidate and Dexmethylphenidate has one brand name on record: Azstarys. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Serdexmethylphenidate and Dexmethylphenidate: Manufacturers and Labelers
One company lists Serdexmethylphenidate and Dexmethylphenidate products with the FDA. By number of product records, the largest are Commave Sub, LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Serdexmethylphenidate and Dexmethylphenidate Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Commave Sub, LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →